Latest XVIVO News & Updates

See the latest news and media coverage for XVIVO. We track all announcements, press releases, and industry mentions in real time, all in one place.

XVIVO

Organ preservation and transplantation technology company

xvivogroup.com

Headquarters: Mölndal, Sweden
Founded year: 1998
Company type: Public company
Number of employees: 200–320
Industry: Biotechnology & Medical Research

Last updated October 22

Latest news about XVIVO

In short: XVIVO's Q3 profit rose, its heart system won CE marks and NICE backed its lung device.

Company announcements

October 22 XVIVO

XVIVO reports strong financial results and regulatory progress

Net sales reached SEK 252.6 million in Q3 with robust organic growth. The Heart Assist Transport system secured CE marking and FDA review entry, while CFO roles transitioned.

August 11 XVIVO

XVIVO receives CE certificates for its heart preservation technology

The XVIVO Heart Assist Transport system uses HOPE to extend preservation time, reducing severe complications by 38% and improving survival rates.

July 14 XVIVO

XVIVO reports strong Q2 2026 financial results with significant growth

Organic sales grew 36% to SEK 239 million. Thoracic segment led expansion, while regulatory submissions for Heart and Liver assist technologies progressed.

July 14 XVIVO

XVIVO reports strong growth and good profitability

Net sales increased by 21 percent. The EBITDA margin was 20 percent. CFO transitions to a new role.

Media coverage

October 21 AffärsVärlden

Xvivo Perfusions result was higher than expected

Revenue increased by 33.6 percent to 252.6 million SEK (189.1). The result can be compared with Modular Finance's analyst consensus, which stood at 238. Organic sales growth was 32...

October 21 RTTNews

Xvivo Perfusion AB Q3 Income Climbs

Xvivo Perfusion AB (XVIVO.ST) announced a profit for its third quarter that Increased, from last year The company's bottom line came in at SEK44.62 million...

August 20 Finanznachrichten

XVIVO receives CE certificates for groundbreaking heart preservation technology

Gothenburg/Berlin (ots) - - The CE certifications enable the broader use of the innovative XVIVO technology and improve access to heart transplants in Europe. XVIVO gives the CE mark...

August 10 Life Sciences Sweden

Xvivo's heart technology CE-marked - "A decisive moment"

The standard method for storing donated hearts for transplantation is to keep them cooled at four degrees in a potassium solution in a cooler with the help of ice...

Never miss news about XVIVO

Track XVIVO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.